Amarin Corporation plc(NASDAQ:AMRN) 
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing t...
Website: http://www.amarincorp.com
Founded: 1989
Full Time Employees: 965
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 8.40
H 8.40
L 7.80
C 8.00
V 2,556,077
10EMA 8.00
20EMA 8.00
60EMA 8.00
120EMA 8.00
250EMA 8.00